Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The DMG Collaborative is a global research network and funding consortium dedicated to finding a cure for Diffuse Midline Glioma (DMG), including Diffuse Intrinsic Pontine Glioma (DIPG). Formed by a partnership of leading pediatric cancer foundations, the organization facilitates high-impact research by funding multi-institutional studies and promoting open data sharing among scientists. The collaborative supports a diverse portfolio of projects ranging from basic molecular biology to early-phase clinical trials investigating novel therapeutics like imipridones and CAR-T cell therapies. By centralizing resources and fostering international cooperation, the DMG Collaborative seeks to accelerate the development of effective treatments for these aggressive and currently terminal pediatric brain tumors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DMG Collaborative.